Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Amlodipine passage into breast milk in lactating women with pregnancy-induced hypertension

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: NAITO, Takafumi (Hamamatsu University School of Medicine, Hospital Pharmacy, Hamamatsu, Japan)
  • Co-author(s): Kubono, Naoko (Hamamatsu University School of Medicine, Hamamatsu, Japan)
    Deguchi, Shuhei (Sawai Pharmaceutical Co., Ltd., Osaka, Japan)
    Sugihara, Masahisa (Sawai Pharmaceutical Co., Ltd., Osaka, Japan)
    Itoh, Hiroaki (Hamamatsu University School of Medicine, Hamamatsu, Japan)
    Kanayama, Naohiro (Hamamatsu University School of Medicine, Hamamatsu, Japan)
    Kawakami, Junichi (Hamamatsu University School of Medicine, Hamamatsu, Japan)
  • Abstract:

    Background: Amlodipine is a dihydropyridine calcium channel blocker empirically prescribed for the pregnancy-induced hypertension. Few clinical reports have been published on the amlodipine passage into breast milk in lactating women.

    Aims: The aim of this study was to evaluate the plasma exposure of amlodipine and its passage into breast milk in ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses